The munKNEE Pure-Play "Seed-to-Sale" Pot Stocks Index declined -5.8% in November and is now DOWN -26.8% YTD. 

Image Source: Unsplash

The "Seed-to-Sale" Pot Stocks Index consists of the 23 non-ancillary (i.e. pure-play) vertically integrated cannabis companies whose stocks trade for at least US$1/share, have a market cap of at least US$300M and trade on one or more of the Canadian and/or American stock exchanges. Six of the 23 index constituents that meet that criteria are Canadian Licensed Producers (LPs) and 17 are American Multi-State Operators (MSOs) and those 23 companies represent 10% of the total universe of 218 cannabis and ancillary companies currently trading.

9 of the constituents changed prices by more than 10% and another 4 by at least 5%, as follow, in descending order: (* designates an MSO stock; ** designates a LP stock) 

1. Columbia Care* (CCHWF): +6.7%
2. Trulieve* (TCNNF): +6.0%
3. Green Thumb* (GTBIF): +5.5%
4. Organigram** (OGI): -7.7%
5. Goodness Growth* (GDNSF): -10.1%
6. Acreage* (ACRDF/HF): -11.1%
7. Cronos** (CRON): -12.7%
8. Canopy Growth** (CGC): -15.2%
9. Charlotte's Web* (CWBHF): -20.7%
10. Ascend Wellness* (AAWH): -23.2%
11. Hexo** (HEXO): - 24.5%
12. Ayr Wellness* (AYRWF): -25.5%
13. Valens* (VLNCF): -26.7%

In summary, the 6 Licensed Producers** went DOWN an average of -9.2% while the 17 Multi-State Operators* went DOWN an average of -4.9%.

You are encouraged to visit the company websites, click on the hyperlinked symbols in this article of those stocks you are interested in and review their latest financial statements and commentary as found in the TalkMarkets data there.